Bortezomib-associated cutaneous vasculitis [1]

British Journal of Dermatology

Volumn 157, Issue 4, 2007, Pages 799-801

  Garcia Navarro, X ^a   Puig, L ^a   Fernandez Figueras M T ^b   Dalmau, J ^a   Roe, E ^a   Alomar, A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; IMMUNOGLOBULIN A; INTERFERON; PREDNISONE;

ADULT; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; EOSINOPHIL; EPIDERMIS HYPERPLASIA; ERYTHEMATOSQUAMOUS SKIN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NECROSIS; PRIORITY JOURNAL; PURPURIC RASH; SKIN BIOPSY; TREATMENT RESPONSE; VASCULITIS;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEASE INHIBITORS; PYRAZINES; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 34548562013     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08073.x     Document Type: Letter

References (7)

1. Min CK, Lee S, Kim YJ et al. Cutaneous leucocytoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines. Eur J Haematol 2006 76 : 265 8.
2. Gerecitano J, O'Connor O. Bortezomib in the treatment of mantle cell lymphoma: a case study and review of the literature. http://www. cancerpublications.com/newsletter/hematological/CaseStudies/CS_Lym_v3n4/ CSLymph_v3n4.pdf (accessed 21 August 2006).
3. Pour L, Hajek R, Zdenek A et al. Skin lesions induced by bortezomib. Haematologica 2005 90 (Suppl. 12 ECR44.
4. Van Regenmortel N, van de Voorde K, de Raeve H et al. Bortezomib-induced Sweet's syndrome. Haematologica 2005 90 (Suppl. 12 ECR43.
5. Agterof MJ, Biesma DH. Images in clinical medicine. Bortezomib-induced skin lesions. N Engl J Med 2005 352 : 2534.
6. Knoops L, Jacquemain A, Tennstedt D et al. Bortezomib-induced Sweet's syndrome. Br J Haematol 2005 131 : 142.
7. Gerecitano J, Goy A, MacGregor-Cortelli B et al. Drug induced cutaneous vasculitis in patients with non-Hodgkin's lymphoma receiving bortezomib: a possible surrogate marker of response. Blood 2005 106 : 3334 (Abstract).